← Back
Data updated: Mar 10, 2026
EZRA VENTURES
Neurology
EZRA VENTURES is a generic drug manufacturer focused on Neurology.
2023
Since
1
Drugs
-
Trials
31
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
FINGOLIMOD HYDROCHLORIDE 2026-02-24
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-18
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-02-18
Labeling
FINGOLIMOD HYDROCHLORIDE 2026-01-16
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-04-28
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-04-28
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-02-19
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-01-22
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-01-22
Labeling
FINGOLIMOD HYDROCHLORIDE 2025-01-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2023-12-06
- Latest
- 2023-12-06
- Applications
- 1